Showing results (951-960 of 1,033) with videos related to

Sort By:
Pageof 104
The Lancet. Respiratory Medicine|January 18, 2017
Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trialFrancisco M Marty, Joan Vidal-Puigserver, Carol Clark, et al.
The Lancet. Respiratory Medicine|January 15, 2017
Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based studyDavid Montani, Barbara Girerd, Xavier Jaïs, et al.
The Lancet. Respiratory Medicine|January 17, 2017
Occupational lung diseases: from old and novel exposures to effective preventive strategiesPaul Cullinan, Xavier Muñoz, Hille Suojalehto, et al.
The Lancet. Respiratory Medicine|October 4, 2016
Lung volume reduction for emphysemaPallav L Shah, Felix J Herth, Wouter H van Geffen, et al.
The Lancet. Respiratory Medicine|May 25, 2015
Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional dataSu Yeon Kim, James Diggans, Dan Pankratz, et al.
The Lancet. Respiratory Medicine|March 23, 2023
Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trialDjillali Annane, Sean J Pittock, Hrishikesh S Kulkarni, et al.
The Lancet. Respiratory Medicine|April 19, 2015
Sleep apnoea and the brain: a complex relationshipIvana Rosenzweig, Martin Glasser, Dora Polsek, et al.
The Lancet. Respiratory Medicine|April 15, 2021
Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure: a four-arm, parallel-group, randomised, controlled trialCaroline O Cobb, Jonathan Foulds, Miao-Shan Yen, et al.
The Lancet. Respiratory Medicine|April 19, 2021
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trialJoseph K Han, Claus Bachert, Wytske Fokkens, et al.
The Lancet. Respiratory Medicine|April 17, 2021
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trialTracy J Ruckwardt, Kaitlyn M Morabito, Emily Phung, et al.
Pageof 104